Ramkrishna Pal

Employment

• Farcast Biosciences Pvt. Ltd., Scientist
  2019 - Present
• Indian Institute of Science Education and Research Kolkata SERB-National Post-doctoral Fellow
  2017 - 2019
• Vinformax Dimensions Technology Pvt.Ltd. Content Writer and Reviewer
  2016 - 2017
• Durgapur College of Commerce and Science Part time lecturer of Biochemistry
  2015 - 2016

Education

• Assam University Ph.D.
  2010 - 2016
• Periyar University M.Sc.
  2006 - 2008
• University of Burdwan B.Sc.
  2003 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Anticancer efficacy of noble metal nanoparticles relies on reprogramming tumor-associated macrophages through redox pathways and pro-inflammatory cytokine cascades
  Mahuya Sengupta, Ramkrishna Pal, Anupam Nath

  +4 more

  • Biswajit Chakraborty
  • Leichombam Mohindro Singh
  • Biswajit Das
  • Sujit Kumar Ghosh
  Cellular and Molecular Immunology 2018 DOI: 10.1038/s41423-018-0046-7
  +Save
• Gold‑manganese oxide nanocomposite suppresses hypoxia and augments pro-inflammatory cytokines in tumor associated macrophages
  Anupam Nath, Ramkrishna Pal, Leichombam Mohindro Singh

  +5 more

  • Himadri Saikia
  • Hasimur Rahaman
  • Sujit Kumar Ghosh
  • Ritwik Mazumder
  • Mahuya Sengupta
  International Immunopharmacology 2018 DOI: 10.1016/j.intimp.2018.02.021
  +Save
• A comparative study on the antioxidant and immunomodulatory properties of curcumin conjugated gold nanospheres and free curcumin
  Journal of Applied Pharmaceutical Science 2017 DOI: 10.7324/JAPS.2017.71108
  +Save
• Dose response study of a novel gold-manganese oxide nano-composite in an in vivo murine model
  Journal of Applied Pharmaceutical Science 2017 DOI: 10.7324/JAPS.2017.71204
  +Save
• Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma
  Cellular and Molecular Immunology 2016 DOI: 10.1038/cmi.2015.05
  +Save
• Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach
  International Immunopharmacology 2016 DOI: 10.1016/j.intimp.2016.06.006
  +Save